SCHEMBL1940876

SCHEMBL1940876

CSc1nn2ccccc2c1NC(=O)OC(C)(C)C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 6/20 0.41
ATR Q13535 1/20 0.37
ALDH1A1 P00352 3/20 0.37
CYP1A2 P05177 2/20 0.37
CYP3A4 P08684 2/20 0.37
CYP2D6 P10635 2/20 0.37
CYP2C9 P11712 2/20 0.37
TSHR P16473 2/20 0.37
CYP2C19 P33261 2/20 0.37
HSD17B10 Q99714 1/20 0.37
BRD9 Q9H8M2 1/20 0.36
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
GAA P10253 1/20 0.36
PDE5A O76074 1/20 0.34
MIF P14174 1/20 0.34
PDE4A P27815 1/20 0.34
ADORA2A P29274 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17051119 0.85 BRD4 (0.43) BRD4ATRBRD9NPC1RAB9A
SCHEMBL4035121 0.83 BRD4 (0.39) BRD4ATRALDH1A1BRD9NPC1
SCHEMBL1942386 0.82 HTR6 (0.40) ALDH1A1CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL1943580 0.79 BRD4 (0.36) BRD4ATRALDH1A1CYP1A2CYP3A4
SCHEMBL1941286 0.79 BRD4 (0.36) BRD4ATRBRD9NPC1RAB9A
SCHEMBL12659342 0.76 HTR6 (0.38) ALDH1A1CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL1941351 0.75 LCK (0.35) BRD4ATRBRD9NPC1RAB9A
SCHEMBL21436566 0.72 EPHB3 (0.54) ALDH1A1BRD9NPC1RAB9AMEN1
SCHEMBL31324819 0.71 EGFR (0.46) BRD4ALDH1A1CYP1A2CYP3A4CYP2D6
SCHEMBL7826478 0.69 MEN1 (0.36) ALDH1A1CYP1A2CYP3A4CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1389618-B1 PYRAZOLO 1,5-A PYRIDINES AND MEDICINES CONTAINING THE SAME EISAI R&D MAN CO LTD (JP) 2011-06-15 EP disclosed
US-7625925-B2 Pyrazolo[1,5-a]pyridines and medicines containing the same EISAI R&D MANAGEMENT CO., LTD (JP) 2009-12-01 US disclosed
EP-1555265-B1 7-PHENYL PYRAZOLOPYRIDINE COMPOUNDS EISAI R&D MAN CO LTD (JP) 2009-03-25 EP disclosed
EP-1555265-B1 7-PHENYL PYRAZOLOPYRIDINE COMPOUNDS EISAI R&D MAN CO LTD (JP) 2009-03-25 EP disclosed
US-20080076943-A1 7-PHENYLPYRAZOLOPYRIDINE COMPOUNDS HIBI SHIGEKI 2008-03-27 US disclosed
US-20080076943-A1 7-PHENYLPYRAZOLOPYRIDINE COMPOUNDS HIBI SHIGEKI 2008-03-27 US disclosed
US-20080076943-A1 7-PHENYLPYRAZOLOPYRIDINE COMPOUNDS HIBI SHIGEKI 2008-03-27 US disclosed
US-7323569-B2 7-phenylpyrazolopyridine compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2008-01-29 US disclosed
US-7323569-B2 7-phenylpyrazolopyridine compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2008-01-29 US disclosed
US-7323569-B2 7-phenylpyrazolopyridine compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2008-01-29 US disclosed
US-7176216-B2 7-phenylpyrazolopyridine compounds EISAI CO., LTD. (JP) 2007-02-13 US disclosed
US-7176216-B2 7-phenylpyrazolopyridine compounds EISAI CO., LTD. (JP) 2007-02-13 US disclosed
US-7176216-B2 7-phenylpyrazolopyridine compounds EISAI CO., LTD. (JP) 2007-02-13 US disclosed
US-20060235011-A1 7-Phenyl pyrazolopyridine compounds EISAI CO.LTD. (JP) 2006-10-19 US disclosed
US-20060217348-A1 Pyrazolo[1,5-a] pyridines and medicines containing the same EISAI R&D MANAGEMENT CO., LTD. (JP) 2006-09-28 US disclosed
US-7091215-B2 Pyrazolo[1,5-a]pyridines and medicines containing the same EISAI CO., LTD. (JP) 2006-08-15 US disclosed
EP-1555265-A1 7-PHENYL PYRAZOLOPYRIDINE COMPOUNDS Eisai Co., Ltd. (JP) 2005-07-20 EP disclosed
US-20040224974-A1 7-phenylpyrazolopyridine compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-11-11 US disclosed
US-20040122039-A1 Pyrazolo[1,5-a]pyridines and medicines containing the same EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-06-24 US disclosed
EP-1389618-A1 PYRAZOLO 1,5-A]PYRIDINES AND MEDICINES CONTAINING THE SAME Eisai Co., Ltd. (JP) 2004-02-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040224974-A1 7-phenylpyrazolopyridine compounds CRHR1, MC2R, CRH BRD4 621/4885ATR 2985/4885ALDH1A1 2616/4885
US-20080076943-A1 7-PHENYLPYRAZOLOPYRIDINE COMPOUNDS MC2R, CRHR1, CRHR2 BRD4 557/4885ATR 3145/4885ALDH1A1 3348/4885
US-20040122039-A1 Pyrazolo[1,5-a]pyridines and medicines containing the same XDH, NR3C1, NR5A1 BRD4 296/4885ATR 1371/4885ALDH1A1 1142/4885
US-20060235011-A1 7-Phenyl pyrazolopyridine compounds MC2R, CRHR1, CRHR2 BRD4 618/4885ATR 2993/4885ALDH1A1 3334/4885
US-20060217348-A1 Pyrazolo[1,5-a] pyridines and medicines containing the same NR3C1, NR3C2, NR5A2 BRD4 206/4885ATR 1953/4885ALDH1A1 2022/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.